Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (723) Web-based and Mobile Health Interventions (4321) Telehealth and Telemonitoring (2258) Decision Support for Health Professionals (1691) Clinical Communication, Electronic Consultation and Telehealth (826) Pharmacovigilance (185) Patient-Reported Outcome Measures (PROMs) (397) Patient Reported Measures and Outcomes in Participatory Medicine (51)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/48386, first published .
Woman using a tablet to fill out a swelling symptom questionnaire

Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial

Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial

Authors of this article:

André Manuel da Silva Lopes1 Author Orcid Image ;   Sara Colomer-Lahiguera1 Author Orcid Image ;   Célia Darnac1, 2 Author Orcid Image ;   Stellio Giacomini1 Author Orcid Image ;   Sébastien Bugeia3 Author Orcid Image ;   Garance Gutknecht3 Author Orcid Image ;   Gilliosa Spurrier-Bernard4 Author Orcid Image ;   Michel Cuendet5 Author Orcid Image ;   Fanny Muet1 Author Orcid Image ;   Veronica Aedo-Lopez6 Author Orcid Image ;   Nuria Mederos2 Author Orcid Image ;   Olivier Michielin3 Author Orcid Image ;   Alfredo Addeo3 Author Orcid Image ;   Sofiya Latifyan5 Author Orcid Image ;   Manuela Eicher1, 2 Author Orcid Image
Article Authors Cited by (4) Tweetations (2) Metrics

Journals

  1. Falade A, Boulanger M, Hsu K, Sarathy R, Fadden R, Reynolds K, Traeger L, Temel J, Greer J, Petrillo L. Learning about and living with toxicity: a qualitative study of patients receiving immune checkpoint inhibitors for melanoma or lung cancer and their caregivers. Supportive Care in Cancer 2024;32(10) View
  2. Lambert S, Soldera S, Kazdan J, Frati F, Slominska A, Boutin M, Samouelian V, Letendre C, Bilodeau K, Howell D, Breton K, Gratton M. Patient-reported outcome measure (PROM) programs for monitoring symptoms among patients treated with immunotherapy: a scoping review. JNCI Cancer Spectrum 2024;8(6) View
  3. Lopes A, Giacomini S, Ulahannan A, Darnac C, Bugeia S, Gutknecht G, Colomer-Lahiguera S, Spurrier-Bernard G, Latifyan S, Addeo A, Michielin O, Eicher M. Acceptability of an Electronic Patient-Reported Outcomes-Based Model of Care to Monitor Symptoms Related to Cancer Treatment with Immune Checkpoint Inhibitors: Results from the IePRO Randomized Controlled Trial. Seminars in Oncology Nursing 2025;41(4):151903 View
  4. Xia Y, Wei X, Wang Y, Shi Z, He P. Electronic symptom monitoring of patient-reported outcomes among patients with hepatocellular carcinoma during immunotherapy (PRIME-HCC): protocol for a randomised controlled trial. BMJ Open 2026;16(5):e116199 View